ARTICLE | Company News
Pfizer, Schwarz Pharma deal
April 17, 2006 7:00 AM UTC
PFE plans to acquire from SRZ exclusive worldwide rights to fesoterodine to treat overactive bladder (OAB). SRZ submitted an NDA on March 27 and an MAA on March 8 for the anti-muscarinic agent. SRZ wi...